Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies
Crossref DOI link: https://doi.org/10.1136/bmjresp-2021-000998
Published Online: 2021-12-02
Published Print: 2021-12
Update policy: https://doi.org/10.1136/crossmarkpolicy
Bresnick, Kathryn
Arteaga-Solis, Emilio
Millar, Stefanie J
Laird, Glen
LeCamus, Cecile
Funding for this research was provided by:
Vertex Pharmaceuticals
License valid from 2021-12-02